Quantcast
Last updated on April 16, 2014 at 11:32 EDT

Latest Needle aspiration biopsy Stories

2012-07-17 06:25:07

SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., July 17, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the publication of new data suggesting that routine clinical use of Veracyte's Afirma® Gene Expression Classifier helps to significantly reduce the number of surgeries performed on patients whose thyroid nodule cytology results...

2012-06-01 10:22:01

MADISON, N.J., June 1, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically available to identify mutations associated with four gene markers indicated by the American Thyroid Association for the clinical...

2012-04-16 10:10:33

Authors explain false negative results in May JTO Screening for lung cancer with low dose CT scans has been shown to save lives.  However, research shows that when CT scans reveal nodules in the lungs, it is not cancerous 96 percent of the time. As a result, scientists are looking for ways to more accurately make a diagnosis. One way is by using a CT guided transthoracic fine needle aspiration. Research presented in the May 2012 issue of the International Association for the...

2012-02-13 05:00:00

Electromagnetic Navigation Bronchoscopy uses GPS-like technology to locate, biopsy and prepare to treat a lesion in the lung. Youngstown, Ohio (PRWEB) February 13, 2012 The St. Elizabeth Pulmonary Health and Research Center now offers a new procedure called Electromagnetic Navigation Bronchoscopy (ENB) that offers patients a minimally-invasive option to locate, enable biopsy and plan treatment for lesions detected deep in the lung. St. Elizabeth is one of the first in the area to provide...

2012-02-06 07:30:00

NATICK, Mass., Feb. 6, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples under Endoscopic Ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointestinal tract. The Expect 19 Flex Needle is designed with a Nitinol construction for improved flexibility compared to existing EUS-Fine Needle Aspiration (FNA) devices and a...

2012-02-01 11:08:30

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a study in the February issue of the Journal of the American College of Radiology. Surgical breast biopsies are more invasive than needle biopsies, requiring an incision and the use of general anesthesia. Results from a previous study in 2011 in a surgical journal suggested that surgery is used for 30 percent of breast biopsies, an excessive number. However, in response, the...

2012-01-31 07:15:00

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of Mark Spring as chief financial officer. "We are delighted that Mark Spring has joined the Veracyte team," said Bonnie Anderson, Veracyte's cofounder and chief executive officer. "His extensive experience as a CFO and senior finance leader in both public and private healthcare companies will...

2012-01-09 08:00:00

SOUTH SAN FRANCISCO, Calif., Jan. 9, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company's Afirma Gene Expression Classifier for use in thyroid nodule diagnosis. This means that Veracyte's genomic test is now accessible to 40 million Medicare patients nationwide....

2011-09-01 07:15:00

SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that new data from researchers at Johns Hopkins University School of Medicine suggest that routine use of its Afirma® Gene Expression Classifier for clarifying inconclusive results on thyroid nodule fine needle aspiration (FNA) samples will improve patient care and save the healthcare system money....

2011-05-09 07:30:00

NATICK, Mass., May 9, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and international launch of its Expect(TM) Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract. The Expect Needle received FDA clearance and CE Mark approval earlier this year and is being marketed in the U.S., Europe and other international markets. Endoscopic...